HC Wainwright & Co. Maintains Buy on Biodesix, Raises Price Target to $27

Benzinga · 1d ago
HC Wainwright & Co. analyst Yi Chen maintains Biodesix (NASDAQ:BDSX) with a Buy and raises the price target from $26 to $27.